UNSPSC 51112513: Melphalan

This classification denotes a nitrogen mustard compound with the molecular formula C13H18Cl2N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q41OR9510P, chemically known as l-phenylalanine, 4-(bis(2-chloroethyl)amino)- but more generally known as melphalan, which bears US NIH Compound Identifier 4053. European Medicines Agency schedules Melphalan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08728MIG.

UNSPSC 51112513 Melphalan, a Commodity code, covers procurement of this nitrogen mustard chemotherapy agent used primarily in treating multiple myeloma and other hematologic malignancies. State and local governments purchase melphalan through their health departments, public hospital systems, cancer centers, and correctional health services to stock inpatient oncology units and infusion clinics. The drug is typically sourced as a sterile injectable powder requiring reconstitution, and procurement often includes multiple vial strengths and formulations to meet institutional formulary requirements. Health agencies and public teaching hospitals represent the primary buying bodies; school districts and municipal general-services departments do not typically appear as buyers under this code.

No recent state or local contract opportunities for melphalan appear in current procurement records. The code represents a specialized pharmaceutical category with narrow clinical demand concentrated in established public health-system supply chains, and solicitations under it arise infrequently and often through standing cooperative purchasing agreements or state pharmaceutical contracts rather than as discrete RFP or RFQ notices. Firms seeking to compete should monitor state health department procurement portals, state pharmaceutical cooperative-contracting vehicles, and public hospital group purchasing organization postings for infrequent openings, rather than expect regular opportunity flow.